Single agent combination chemotherapy in the adjuvant therapy for pancreatic cancer: 2nd vote and conclusions

Date 10 September 2017
Event ESMO 2017 Congress
Session Single agent or combination chemotherapy in the adjuvant therapy for pancreatic cancer
Topics Anti-Cancer Agents & Biologic Therapy
Pancreatic Cancer
Gastrointestinal Cancers
Presenter Thomas Seufferlein
Authors T. Seufferlein
  • Department Of Internal Medicine I  , Ulm Medical University, 89081 - Ulm/DE